US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

17.74

0.0000

Volume:5K

Turnover:95.41K

Market Cap:104.67M

PE:- -

High:17.74

Open:17.74

Low:17.74

Close:17.74

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:6.09

T/O Rate:0.09%

Dividend:0.71

Dividend Rate:4.03%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer

Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial

MT Newswires Live

Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint

INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target

HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off

JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase

AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer

Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC

THOMSON REUTERS

China's Clover Biopharma H1 Revenue Drops Sharply, Flags Going-Concern Doubt

Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer

THOMSON REUTERS

Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint

THOMSON REUTERS

Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate

THOMSON REUTERS

WuXi Biologics (Cayman) (SEHK:2269) Shares Climbed, So What Is Driving Attention Now?

Simply Wall St.

WuXi XDC Grants 342,300 Restricted Shares to Employees Under 2024 Share Scheme

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

WuXi Biologics Reports Strong Profitable Growth in H1 2026

THOMSON REUTERS

WuXi Biologics H1 Net Profit up on Margin Expansion

Wuxi Bio's Interim Results Exceed Expectations and Break Broker Targets, with Accelerated Manufacturing Growth Reinforcing Long-Term Investment Thesis

Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals

CSPC Pharma's Recombinant RSV Vaccine Wins US Clinical Trial Clearance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/KURE/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.74,"timestamp":1789392937509,"preClose":17.74,"halted":0,"volume":5235,"delay":0,"changeRate":0,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-14 09:35:56 EDT","open":17.74,"high":17.74,"low":17.74,"amount":95410.25168999999,"amplitude":0,"askPrice":18.45,"askSize":500,"bidPrice":18.11,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.74,"sharesOutstanding":4750002,"nav":17.75,"aum":104708978.23,"dividendRate":0.040293,"bidAskSpread":0.008219,"postHourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"volumeRatio":6.09327,"impliedVol":0.5416,"impliedVolPercentile":0.8406},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":6.09327,"shares":5900168,"dividePrice":0.7148,"high":17.74,"amplitude":0,"preClose":17.74,"low":17.74,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":17.74,"eps":0,"divideRate":0.040293,"volume":5235,"delay":0,"ttmEps":0,"open":17.74,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.9,"twentyDayClose":18.43,"sixtyDayClose":14.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1147226125","title":"AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1147226125","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147226125?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:31","pubTimestamp":1787711462,"startTime":"0","endTime":"0","summary":"Shares of AKESO (09926) surged more than 9% during intraday trading before paring gains to trade 6.81% higher at HK$94.85, with turnover reaching HK$814 million. The sharp move followed the company's...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","LU2399975544.HKD","BK1574","LU0348784397.USD","LU2488822045.USD","LU0417516571.SGD","IE00B543WZ88.USD","LU0634319403.HKD","LU0348827113.USD","LU0348783233.USD","LU0348825331.USD","LU1794554557.SGD","BK1161","LU2778985437.USD","IE00BPRC5H50.USD","LU0417516738.SGD","LU2476274308.USD","LU0561508036.HKD","LU2476274720.SGD","09926","LU0417516902.SGD","LU0348766576.USD","BK4134","LU1961090484.USD","LU0348735423.USD","KURE","LU0540923850.HKD","IE00B5MMRT66.SGD","LU1720050803.USD","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766269","title":"Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766269","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766269?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:41","pubTimestamp":1787708502,"startTime":"0","endTime":"0","summary":"Akeso  said its PD-1/VEGF bispecific antibody ivonescimab plus chemotherapy met the primary endpoint in a Phase 3 trial for first-line treatment of advanced biliary tract cancer.The trial met its primary endpoint of overall survival, with key secondary endpoints of progression-free survival and objective response rate also met, according to a Wednesday filing with the Hong Kong bourse.The HARMONi-GI1 study enrolled 682 patients, marking ivonescimab's first positive Phase 3 result in gastrointestinal tumors, Akeso said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0348735423.USD","LU2476274308.USD","LU2476274720.SGD","IE00B543WZ88.USD","LU0417516902.SGD","LU1720050803.USD","LU0348784397.USD","LU0348783233.USD","LU1794554557.SGD","LU2778985437.USD","IE00B5MMRT66.SGD","BK1574","IE00BPRC5H50.USD","LU2488822045.USD","LU0634319403.HKD","LU0348827113.USD","LU0417516738.SGD","LU0561508036.HKD","LU2399975544.HKD","LU0540923850.HKD","09926","LU0348767384.USD","LU0348766576.USD","LU1961090484.USD","KURE","BK1161","LU0348825331.USD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766696","title":"Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766696","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766696?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:29","pubTimestamp":1787707747,"startTime":"0","endTime":"0","summary":"BRIEF-Akeso Says Ivonescimab Plus Chemo Meets Primary EndpointAug 26 (Reuters)-Akeso Inc9926.HK:IVONESCIMAB PLUS CHEMO MEETS PRIMARY ENDPOINT WITH SIGNIFICANT OS BENEFIT IN 1L BTCFurther company coverage:9926.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0634319403.HKD","IE00BPRC5H50.USD","LU2399975544.HKD","IE00B543WZ88.USD","LU0540923850.HKD","LU0348767384.USD","09926","LU2476274720.SGD","LU1961090484.USD","BK1574","LU0417516738.SGD","LU0417516571.SGD","LU0417516902.SGD","LU1794554557.SGD","LU1720050803.USD","LU0561508036.HKD","LU2488822045.USD","LU0348783233.USD","LU2476274308.USD","KURE","LU0348735423.USD","LU2778985437.USD","LU0348825331.USD","LU0348784397.USD","LU0348827113.USD","BK1161","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114601608","title":"INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1114601608","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114601608?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:28","pubTimestamp":1787707707,"startTime":"0","endTime":"0","summary":"Shares of INNOVENT BIO (01801) opened more than 6% higher on Thursday, extending gains to 6.49% at HK$106.60 with turnover reaching HK$28.73 million in early trading.The rally follows the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","HK0000165453.HKD","LU0463099449.HKD","BK1583","VXUS","BK4585","LU2097828805.USD","LU2097828474.EUR","LU2242644610.SGD","LU0502904849.HKD","LU2097828557.USD","LU1188198961.HKD","LU2488822045.USD","BK4588","BK1161","LU1969619763.USD","LU2328871848.SGD","LU0244354667.USD","KCAI","LU2097828714.EUR","LU2097828631.EUR","BK1589","LU0326950275.SGD","LU0455707207.USD","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115078027","title":"HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1115078027","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115078027?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:17","pubTimestamp":1787707028,"startTime":"0","endTime":"0","summary":"Key corporate developments this week: GenFleet Therapeutics-B (02595) has initiated a Phase II study evaluating GFH375, an oral KRAS G12D inhibitor, as a first-line treatment for non-small cell lung...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU0417516902.SGD","LU2778985437.USD","KURE","BK1586","BK1155","LU2399975544.HKD","LU1720050803.USD","LU0348735423.USD","VXUS","02595","LU0540923850.HKD","LU0634319403.HKD","BK1237","LU0348827113.USD","LU0348825331.USD","00660","BK1518","BK1589","IE00BPRC5H50.USD","KCAI","BK1526","LU0348767384.USD","LU0348766576.USD","09926","LU2476274308.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","LU0348784397.USD","BK4588","LU0561508036.HKD","LU1794554557.SGD","LU0348783233.USD","BK1574","00354","BK4585","LU2476274720.SGD","LU1961090484.USD","LU0417516738.SGD","BK1161","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169767752","title":"JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1169767752","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169767752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 08:10","pubTimestamp":1787703042,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on August 20, JPMorgan increased its holding in INNOVENT BIO (01801) by 2.355 million shares.The purchase was executed at an average price of HK$102.2359...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930490.SGD","LU1548497426.USD","LU0265550946.USD","BK4566","LU0417517546.SGD","LU0345769631.USD","LU0859254822.USD","LU2097828557.USD","IE00B1BXHZ80.USD","LU1670627923.USD","LU0006306889.USD","IE00BBT3K403.USD","LU0820561909.HKD","LU2237443549.SGD","LU0964807845.USD","LU2023250843.SGD","IE00BN8TJ469.HKD","LU0868494617.USD","LU2264538146.SGD","LU0256863902.USD","LU0106261372.USD","LU2505996509.AUD","BK4504","LU0868494708.USD","LU0211326839.USD","LU2023250504.SGD","BK4207","LU2054465674.USD","LU2357305700.SGD","LU0211327993.USD","LU1366192091.USD","LU2430703251.USD","LU0070302665.USD","LU0187121727.USD","LU1551013342.USD","IE00BK4W5L77.USD","IE000M9KFDE8.USD","LU2430703178.SGD","JPM","LU1116320737.USD","LU0345770993.USD","LU2381873111.SGD","LU2756315664.SGD","BK1583","IYG","LU0215105999.USD","XLF","IE00BLSP4239.USD","LU0203345920.USD","LU0323591593.USD","LU1974910355.USD","IE00B3S45H60.SGD","LU1244550221.USD","LU0211326755.USD","BK4533","LU0234570918.USD","LU0320765489.SGD","LU1670628061.USD","LU0820561818.USD","IE00BJTD4N35.SGD","LU2242649171.HKD","BK1161","BK1589","LU0345769128.USD","IE0034235295.USD","LU0149725797.USD","LU2097828714.EUR","LU1668664300.SGD","LU1720051108.HKD","JPO","BK4588","LU2756315318.SGD","IE00BJTD4V19.USD","LU1261432733.SGD","LU2237443622.USD","BK4585","01801","LU2328871848.SGD","IE00BZ1G4Q59.USD","IE00BDCRKT87.USD","LU0320765646.SGD","LU0971096721.USD","TFNS","LU1629891620.HKD","LU0234572021.USD","LU0976567544.SGD","LU2237443382.USD","LU2462157665.USD","LU0882574139.USD","LU1244550577.SGD","LU1894683348.USD","LU0689472784.USD","LU1720051017.SGD","LU1969619763.USD","LU2456880835.USD","LU2357627491.SGD","BK4534","LU0211331839.USD","LU0820562030.AUD","TRUF","LU2023250330.USD","LU2552382132.HKD","LU1917777945.USD","IE0034235303.USD","JPMO","LU0256863811.USD","IE00BHPRN162.USD","IE00B775SV38.USD","FNCL","LU1244550494.USD","LU1496350171.SGD","LU1145028129.USD","BK4581","LU2097828805.USD","LU0787776722.HKD","LU0455707207.USD","IE00BKDWB100.SGD","LU0048584097.USD","LU0170899867.USD","KBWB","LU0310799852.SGD","KURE","LU1162221912.USD","LU0640476718.USD","IE00BKVL7J92.USD","IE00BWXC8680.SGD","LU0942090050.USD","LU1551013425.SGD","LU2213496289.HKD","LU0203347892.USD","SG9999002232.USD","LU2237443978.SGD","LU2097828474.EUR","LU0502904849.HKD","LU0238689110.USD","LU0943347566.SGD","LU1914381329.SGD","LU1496350502.SGD","LU2552382215.SGD","IE00BYXW3230.USD","LU1064131342.USD","LU1363072403.SGD","IE00B1XK9C88.USD","LU1032466523.USD","LU2237443465.HKD","IE00BFXG1179.USD","LU0683600562.USD","LU0326950275.SGD","LU2592432038.USD","LU2746668974.SGD","IYF","FTXO","LU2106854487.HKD","LU0463099449.HKD","LU2237443895.HKD","SG9999002224.SGD","LU2211815571.USD","VFH","IXG","LU2244417387.USD","IE00BLSP4452.SGD","LU0345770308.USD","LU1894683264.USD","LU2242644610.SGD","BK4516","LU1084165304.USD","IE00BK4W5M84.HKD","IE00BDRTCR15.USD","LU0211328371.USD","LU1280957306.USD","LU2417539215.USD","LU0265550359.USD","UYG","LU0208291251.USD","LU2097828631.EUR","LU0496365809.HKD","LU1119994496.HKD","LU2488822045.USD","HK0000165453.HKD","LU0251132253.USD","LU2552382058.USD","LU1988902786.USD","IE00BJLML261.HKD","LU1116320901.HKD","EWH","LU2505996681.GBP","LU2236285917.USD","LU1188198961.HKD","LU0244354667.USD","LU2746668461.USD","LU2430703095.HKD","BK4550","LU0267386448.USD","IE0034235188.USD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197055899","title":"AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1197055899","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197055899?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:42","pubTimestamp":1787701336,"startTime":"0","endTime":"0","summary":"AKESO (09926) has announced that its independently developed, first-in-class bispecific antibody, 依达方® (ivonescimab, PD-1/VEGF), combined with chemotherapy, demonstrated a statistically significant...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","LU2399975544.HKD","III","LU0561508036.HKD","IE00B5MMRT66.SGD","LU0417516738.SGD","LU1961090484.USD","LU0417516902.SGD","LU0634319403.HKD","09926","LU0348783233.USD","LU0348825331.USD","LU2488822045.USD","BK4134","KURE","LU0540923850.HKD","LU0348735423.USD","IE00BPRC5H50.USD","LU0417516571.SGD","LU0348784397.USD","BK1574","IE00B543WZ88.USD","LU0348766576.USD","LU0348767384.USD","LU2476274720.SGD","LU0348827113.USD","LU2476274308.USD","LU2778985437.USD","BK1161","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662685897","title":"Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC","url":"https://stock-news.laohu8.com/highlight/detail?id=2662685897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662685897?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:01","pubTimestamp":1787698884,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0417516571.SGD","LU0348767384.USD","IE00B543WZ88.USD","KURE","LU0348783233.USD","LU0561508036.HKD","BK1574","LU0417516902.SGD","IE00B5MMRT66.SGD","LU2778985437.USD","LU0348766576.USD","LU1961090484.USD","LU0348735423.USD","IE00BPRC5H50.USD","LU2399975544.HKD","LU0417516738.SGD","LU0348784397.USD","LU0348825331.USD","LU1794554557.SGD","LU2476274720.SGD","LU2476274308.USD","LU0540923850.HKD","BK1161","LU0348827113.USD","LU1720050803.USD","09926","LU0634319403.HKD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662505547","title":"China's Clover Biopharma H1 Revenue Drops Sharply, Flags Going-Concern Doubt","url":"https://stock-news.laohu8.com/highlight/detail?id=2662505547","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662505547?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:24","pubTimestamp":1787696645,"startTime":"0","endTime":"0","summary":"China's Clover Biopharma H1 revenue drops sharply, flags going-concern doubtOverviewChina vaccine developer's H1 revenue dropped sharply after ending AdimFlu-S (QIS) sales in ChinaCompany swung to net","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","BK1161","BK1589","LU2097828557.USD","LU2097828714.EUR","LU0463099449.HKD","BK1141","LU2097828805.USD","LU0455707207.USD","KURE","01801","LU2242644610.SGD","LU2328871848.SGD","06118","LU2097828631.EUR","02197","LU1969619763.USD","LU2488822045.USD","BK1583","HK0000165453.HKD","LU2097828474.EUR","LU0502904849.HKD","LU1188198961.HKD","LU0244354667.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752407","title":"Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752407?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B5MMRT66.SGD","LU1961090484.USD","LU2488822045.USD","LU0348766576.USD","LU2778985437.USD","LU1794554557.SGD","09926","LU0540923850.HKD","LU0348784397.USD","LU0634319403.HKD","KURE","LU0417516571.SGD","IE00BPRC5H50.USD","LU0348825331.USD","LU1720050803.USD","BK1574","LU0348767384.USD","IE00B543WZ88.USD","LU0417516738.SGD","LU2399975544.HKD","LU0348827113.USD","LU0348783233.USD","LU0417516902.SGD","LU2476274720.SGD","LU2476274308.USD","BK1161","LU0348735423.USD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662524007","title":"Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662524007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662524007?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","LU1720050803.USD","LU0348767384.USD","LU2476274308.USD","LU0417516738.SGD","LU0348783233.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348766576.USD","LU0348735423.USD","LU1794554557.SGD","LU0348784397.USD","IE00B5MMRT66.SGD","LU2399975544.HKD","LU0417516902.SGD","LU2488822045.USD","BK1161","LU2476274720.SGD","LU0540923850.HKD","LU0634319403.HKD","KURE","09926","LU2778985437.USD","LU0348827113.USD","LU1961090484.USD","LU0561508036.HKD","LU0348825331.USD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662401752","title":"Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2662401752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662401752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2399975544.HKD","LU0348784397.USD","LU2778985437.USD","IE00B543WZ88.USD","LU2476274308.USD","LU1961090484.USD","LU1794554557.SGD","BK1574","IE00B5MMRT66.SGD","LU0417516902.SGD","LU0348825331.USD","LU0348783233.USD","LU1720050803.USD","LU2488822045.USD","LU0348827113.USD","LU0348735423.USD","LU0540923850.HKD","LU0417516571.SGD","09926","KURE","LU0634319403.HKD","LU2476274720.SGD","LU0561508036.HKD","IE00BPRC5H50.USD","LU0348766576.USD","LU0348767384.USD","LU0417516738.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068756","title":"WuXi Biologics (Cayman) (SEHK:2269) Shares Climbed, So What Is Driving Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068756","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068756?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:22","pubTimestamp":1787674955,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) half year earnings in focus\nWuXi Biologics (Cayman) (SEHK:2269) reported half year 2026 earnings, noting higher sales, net income and earnings per share compared with the same period in 2025.\nSee our latest analysis for WuXi Biologics (Cayman).\nAlongside these half year results, WuXi Biologics (Cayman) has seen strong recent momentum, with a 30 day share price return of 33.5% and a 90 day share price return of 54.99%, while the 1 year total shareholder return is...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-shares-climbed-so-what-is-dri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-shares-climbed-so-what-is-dri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0856984785.SGD","LU1242518857.USD","SG9999002562.SGD","LU0029874061.USD","LU0052750758.USD","KURE","LU3063872942.SGD","LU0320764599.SGD","IE00B0JY6N72.USD","LU0417516738.SGD","BK1610","02269","LU0456846285.SGD","LU0181495838.USD","LU0823426308.USD","LU1242518931.SGD","LU0039217434.USD","LU0572944931.SGD","LU0979878070.USD","LU1720050803.USD","LU1794554557.SGD","LU0326950275.SGD","BK1589","LU1688375341.USD","LU0456827905.SGD","LU0819121731.USD","LU0359201612.USD","LU0359202008.SGD","LU0516422440.USD","BK1521","LU0128526141.USD","LU0516422366.SGD","LU0516422952.EUR","LU0327786744.USD","LU0348825331.USD","LU0516423174.USD","LU0823426480.USD","LU0708995583.HKD","BK1576","LU0588546209.SGD","LU2039709279.SGD","LU0043850808.USD","LU0307460666.USD","SG9999002463.SGD","LU0417516902.SGD","LU0051755006.USD","LU1880383366.USD","LU0348735423.USD","BK1141","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662307867","title":"WuXi XDC Grants 342,300 Restricted Shares to Employees Under 2024 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2662307867","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662307867?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:55","pubTimestamp":1787666130,"startTime":"0","endTime":"0","summary":"WuXi XDC grants 342,300 restricted shares to employees under 2024 share schemeWuxi XDC Cayman granted 342,300 restricted shares to 13 employees under its 2024 Share Scheme on Aug. 25, 2026.Purchase pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL4q2gL5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","LU0307460666.USD","LU0359201612.USD","LU0516422366.SGD","BK1589","LU1794554557.SGD","SG9999014674.SGD","LU0823426480.USD","LU0588546209.SGD","LU0359202008.SGD","LU0140636845.USD","LU0051755006.USD","SG9999002562.SGD","LU0708995583.HKD","LU0039217434.USD","LU0052750758.USD","LU0326950275.SGD","LU1880383366.USD","LU0516422440.USD","LU0417516902.SGD","LU0456827905.SGD","LU1688375341.USD","BK1141","BK1610","LU0516423091.SGD","LU1242518931.SGD","LU1720050803.USD","LU0572944931.SGD","LU0979878070.USD","KURE","LU0819121731.USD","LU0181495838.USD","02269","LU0348735423.USD","LU3063872942.SGD","LU0856984785.SGD","BK1576","LU0516422952.EUR","LU0823426308.USD","LU2488822045.USD","LU0417516738.SGD","BK1521","LU0043850808.USD","LU0516423174.USD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0029874061.USD","LU0348825331.USD","SG9999002463.SGD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732450","title":"China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732450","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732450?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:48","pubTimestamp":1787662122,"startTime":"0","endTime":"0","summary":"China's Innovent Biologics H1 revenue, profit rise on strong product salesOverviewChina biopharma firm's H1 revenue rose 44.8% yr/yr on strong product sales growthNet profit for H1 grew 50.2% yr/yr, s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU1037948541.HKD","01911","JDOC","FTXH","LU0965509283.SGD","LU0203347892.USD","IXJ","SG9999015986.USD","LU1989772840.SGD","LU0455707207.USD","MEDX","LU2097828631.EUR","01801","LU0098860793.USD","IYH","VHT","LU0234572021.USD","LU0170899867.USD","ABBV","LU2148510915.USD","688331","LU1551013342.USD","LU1732800096.USD","IE00BLSP4452.SGD","TRUH","AGNG","FHLC","IE00B42XCP33.USD","LU2237443895.HKD","LU0029864427.USD","LU2089283258.USD","IE00BVYPNW00.USD","KURE","PJP","688428","RXL","LU1496350171.SGD","LU0942090050.USD","IE00BGHQF631.EUR","IE00B3PB1722.GBP","PPH","01167","GLAM","LU0203345920.USD","IE000MB6IJN5.SGD","LU0456855351.SGD","XLV","BK0239","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662321107","title":"WuXi Biologics Reports Strong Profitable Growth in H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662321107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662321107?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:46","pubTimestamp":1787661974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUACBTSBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999002463.SGD","LU0588546209.SGD","LU0516423174.USD","LU0051755006.USD","LU0572944931.SGD","LU0307460666.USD","LU0359202008.SGD","LU0348825331.USD","LU0823426308.USD","LU0140636845.USD","LU0819121731.USD","LU0456846285.SGD","LU0327786744.USD","LU0516422440.USD","BK1610","BK1521","LU0708995583.HKD","LU0979878070.USD","LU3063872942.SGD","LU1242518857.USD","LU0516422952.EUR","LU1688375341.USD","LU0039217434.USD","LU0417516738.SGD","LU1794554557.SGD","BK1576","LU0326950275.SGD","LU0516423091.SGD","LU0348735423.USD","BK1589","KURE","LU0043850808.USD","LU0052750758.USD","LU0516422366.SGD","IE00B0JY6N72.USD","LU0320764599.SGD","LU0456827905.SGD","LU0417516902.SGD","SG9999002562.SGD","LU1880383366.USD","02269","LU0856984785.SGD","LU1242518931.SGD","LU0029874061.USD","LU0359201612.USD","BK1141","LU0128526141.USD","LU0181495838.USD","LU2039709279.SGD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732647","title":"WuXi Biologics H1 Net Profit up on Margin Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732647","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732647?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:41","pubTimestamp":1787661670,"startTime":"0","endTime":"0","summary":"WuXi Biologics H1 net profit up on margin expansionOverviewChina biologics CDMO's H1 revenue grew 18% yr/yr, net profit attributable up 4%Gross profit margin expanded to 46.2% from 42.7%Growth driven ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXH","PJP","PPH","LU1794554557.SGD","SG9999003800.SGD","LU0949170772.SGD","SG9999015945.SGD","LU0211327993.USD","TRUH","LU0708994859.HKD","LU2133065610.SGD","LU0170899867.USD","02269","SG9999001440.SGD","IE0002270589.USD","AGNG","LU0965509010.AUD","LU1670627923.USD","IYH","LU0289961442.SGD","BK1141","LU0198837287.USD","LU2087621335.USD","LU1983299246.USD","MEDX","BK4533","LU1989772923.USD","XLV","LU1057294990.SGD","LU0234572021.USD","LU0234570918.USD","VHT","IE00BN8TJ469.HKD","SG9999015952.SGD","JDOC","FHLC","ABBV","IE000F7OJYX1.SGD","LU1496350502.SGD","LU1839511570.USD","LU1934455863.HKD","RXL","KURE","IXJ","LU1496350171.SGD","688331","GLAM","LU2237443978.SGD","LU0052750758.USD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157695314","title":"Wuxi Bio's Interim Results Exceed Expectations and Break Broker Targets, with Accelerated Manufacturing Growth Reinforcing Long-Term Investment Thesis","url":"https://stock-news.laohu8.com/highlight/detail?id=1157695314","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157695314?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:37","pubTimestamp":1787661431,"startTime":"0","endTime":"0","summary":"Amid recent pressure on the US dollar's credit profile and increased allocation momentum for Hong Kong-listed equities, Hong Kong's pharmaceutical sector has demonstrated a notable new-high effect...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU0181495838.USD","LU1880383366.USD","LU0819121731.USD","LU1242518857.USD","LU0417516738.SGD","LU0307460666.USD","LU0051755006.USD","LU0823426480.USD","LU0359201612.USD","LU0516422952.EUR","LU0856984785.SGD","BK1521","02269","LU1688375341.USD","LU0516422366.SGD","KURE","LU0708995583.HKD","SG9999002463.SGD","LU0043850808.USD","BK1589","SG9999002562.SGD","BK1576","LU0348825331.USD","LU0326950275.SGD","LU0516422440.USD","LU0128526141.USD","LU0588546209.SGD","LU0516423174.USD","LU0979878070.USD","LU0823426308.USD","LU0417516902.SGD","LU0052750758.USD","LU0516423091.SGD","LU0140636845.USD","LU0359202008.SGD","LU0039217434.USD","LU0456827905.SGD","LU1794554557.SGD","LU0572944931.SGD","LU2039709279.SGD","LU1242518931.SGD","LU0029874061.USD","IE00B0JY6N72.USD","BK1141","BK1610","LU1720050803.USD","LU3063872942.SGD","LU0327786744.USD","LU0348735423.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102179577","title":"Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1102179577","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102179577?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:03","pubTimestamp":1787659392,"startTime":"0","endTime":"0","summary":"Market dynamics took a surprising turn today as the harsh \"devastating\" sanctions threatened by the U.S. yesterday turned out to be more bark than bite. A-shares closed higher while Hong Kong stocks...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJTD4V19.USD","LU2505996681.GBP","IE00B3SWFQ91.USD","LU0359201885.HKD","07788","LU1267930227.SGD","LU1261432733.SGD","LU2592432038.USD","LU1282648689.USD","LU0719512351.SGD","LU3102509885.SGD","LU1119994496.HKD","LU1152091754.HKD","LU0106261372.USD","LU0708995401.HKD","601869","LU2471134796.USD","002703","LU1328615791.USD","NVDB","LU0256863902.USD","LU1003077747.HKD","LU2461242641.AUD","LU1720051108.HKD","IE00B1XK9C88.USD","LU2347655156.SGD","LU2023250330.USD","LU1720050803.USD","LU0345769128.USD","IE0004445015.USD","LU0868494617.USD","LU0689472784.USD","IE0009G5SDU7.USD","SPTE","IE00BF5LJ272.USD","LU1861215975.USD","BK4579","LU2458330169.SGD","LU1923622291.USD","IE00BJLML261.HKD","LU0348816934.USD","LU1804176565.USD","LU0348825331.USD","LU0553294199.USD","LU0795875086.SGD","IE0034235295.USD","LU2054465674.USD","KBDCY","USD","LU1803068979.SGD","BABO","LU0310799852.SGD","LU1934455863.HKD","LU0511384066.AUD","BK4567","LU0173614495.USD","09969","LU1814569148.SGD","LU2433249047.HKD","LU1934455277.USD","LU0327786744.USD","LU0762541174.USD","LU2456880835.USD","BK1519","BK4608","IE000Q6AESB8.SGD","02556","LU0642271901.SGD","LU2506951792.HKD","IE0034235303.USD","LU0197773160.USD","NULC","LU0516422952.EUR","LU1116320737.USD","LU1623119135.USD","LU0149721374.USD","LU1323610961.USD","LU0234570918.USD","FDTX","LU1244550494.USD","LU1831875114.USD","IE00BD6J9T35.USD","LU1244550577.SGD","LU2092937148.SGD","LU0069063385.USD","LU1645745479.HKD","SGXZ31699556.SGD","688428","IE000ITXATA3.USD","LU0323591593.USD","LU1551013425.SGD","LU0175139822.USD","IXN","LU1066051225.USD","LU2929501877.USD","LU2063271972.USD","BK1523","LU0786609619.USD","LU0572944931.SGD","CHAT","LU2860962120.EUR","BK1576","LU2272731865.HKD","BK4529","LU0345770308.USD","LU1989772840.SGD","LU2236285917.USD","LU0094547139.USD","BK1583","LU1718418525.SGD","LU0819121731.USD","LU1202635105.USD","LU0348723411.USD","LU2111349929.HKD","AIFD","BK4504","LU0630378692.HKD","LU0163747925.USD","LU2065171311.SGD","LU2430703095.HKD","SG9999014567.USD","LU0871576103.HKD","LU1974910355.USD","LU0310800379.SGD","IETC","LU0531971595.HKD","LU0795875169.SGD","LU2999663052.SGD","IE00B19Z8X17.USD","LU0210533765.USD","LU1868836757.USD","LU2896262040.SGD","LU2065169927.USD","IE00B3S45H60.SGD","ILDR","LU1282649810.SGD","LU2092627202.USD","HK0000320264.USD","LU2452424414.USD","SG9999014914.USD","LU0476273544.USD","LU0238689110.USD","LU0528227936.USD","LU0274383776.USD","LU0328353924.USD","KBAB","LU2148611432.USD","BK1587","01548","LU2552382058.USD","BK1109","BK1521","LU0326950275.SGD","IE000W1ABFV2.USD","LU1674673691.USD","LU0501845795.SGD","BK1191","LU1935043536.SGD","LU1242518931.SGD","IE00BMPRXN33.USD","SG9999006597.SGD","LU0157215616.USD","LU0081259029.USD","LU2351347302.SGD","LU0072462426.USD","LU1066051811.HKD","LU1691799644.USD","BK1149","LU0307460666.USD","TTEQ","LU0456827905.SGD","LU1046421795.USD","SG9999002224.SGD","LU1066053197.SGD","SG9999014898.SGD","HK0000914660.USD","LU0943347566.SGD","BK4503","LU0823421333.USD","LU1732799900.SGD","NVDS.UK","AIPI","LU0289961442.SGD","LU0823414478.USD","LU2272731600.USD","LU1366192091.USD","SG9999018857.SGD","GB00BDT5M118.USD","LU1153585028.USD","LU0051755006.USD","LU1008478684.HKD","LU1839511570.USD","LU0588546209.SGD","LU0265550946.USD","LU0640798160.USD","LU2271345857.HKD","LU2328871848.SGD","SG9999002828.SGD","LU0964807845.USD","02269","LU1400636657.SGD","LU1069347547.HKD","LU1989764748.USD","TEK","LU1051769294.HKD","IE00BK4W5L77.USD","LU1813983027.USD","ONLN","DRAG","LU0053666078.USD","LU0472753341.HKD","SMHX","LU2187417386.USD","01952","IE00B775SV38.USD","LU1791710400.SGD","LU2954938101.SGD","IE00BKPKM429.USD","LU2462157665.USD","LU0323239441.USD","LU1366333091.USD","LU1983260115.SGD","SG9999014906.USD","LU0466842654.USD","LU2213496289.HKD","LU2476274308.USD","LU2487616109.SGD","LU2488822045.USD","LU0444971666.USD","BK4612","LU1923622614.USD","LU2471134952.CNY","LU0181495838.USD","USXF","LU2100268510.USD","LU0109391861.USD","LU0417517546.SGD","LU0197773673.USD","LU0342679015.USD","LU2226246903.HKD","LU0029874061.USD","LU0856984785.SGD","LU1989772923.USD","BK4533","LU0128525689.USD","LU0417516902.SGD","BK1588","IE00BDRTCR15.USD","LU1712237335.SGD","NVD2.UK","LU0128525929.USD","LU0072462343.USD","LU0918141705.HKD","LU0762540952.USD","LU1267930573.SGD","LU1435385759.SGD","LU0070217475.USD","THMR","LU2430703251.USD","KURE","LU0164865239.USD","IE00BDCRKT87.USD","LU2168564222.USD","BBYY","BK1574","NVDA","LU2381873111.SGD","IE00BYXW3230.USD","LU1935042991.SGD","LU0047713382.USD","LU0052756011.USD","SHOC","IE00B1BXHZ80.USD","LU0316494557.USD","LU2265009873.SGD","06869","LU2360107168.USD","LU2089284900.SGD","SG9999004220.SGD","BK4538","LU0965509101.SGD","LU0211977185.USD","SG9999014880.SGD","LU0820562030.AUD","BK4558","HK0000304797.USD","IE00B7KXQ091.USD","LU0203201768.USD","IE00BJJMRX11.SGD","LU1127390331.HKD","SG9999014559.SGD","LU2237438978.USD","LU1720051017.SGD","LU2106854487.HKD","MCHS","BK1596","LU0323240290.USD","LU2326559502.SGD","IE00BZ1G4Q59.USD","BK4598","LU1914381329.SGD","LU0097036916.USD","LU0128526141.USD","LU0210528500.USD","CNEQ","LU0738911758.USD","IE00B0JY6N72.USD","LU0056508442.USD","LU0661504455.SGD","LU0310800965.SGD","LU0823414551.USD","LU0788109477.HKD","HK0000306685.HKD","BK4565","LU0289739343.SGD","LU0516423174.USD","LU0820561909.HKD","ABFL","BK1610","IE00B5TLWC47.USD","LU0557290698.USD","LU1642822529.SGD","LU2211815571.USD","SG9999014542.SGD","LU0354030438.USD","LU2417539215.USD","WXXWY","LU0140636845.USD","LU1235294995.USD","METV","LU2361045086.USD","IE00BHPRN162.USD","IE00B19Z9505.USD","SGXZ51526630.SGD","LU1721428933.USD","LU0516422440.USD","LU2403377893.USD","SG9999017495.SGD","LU0651946864.USD","IE00B19Z8W00.USD","IE0004086264.USD","LU0359202008.SGD","LFGY","LU0882574139.USD","NVDO","LU2237957902.USD","IE00B4JS1V06.HKD","LU0274383008.USD","LU0823434740.USD","LU1051768304.USD","LU0082616367.USD","SG9999002562.SGD","BK4585","LU0127658192.USD","LU1823568750.SGD","LU0463099449.HKD","IE00BJTD4N35.SGD","LU2756315318.SGD","BK1516","HK0000532082.HKD","LU0831093199.SGD","3NVD.UK","LU1116320901.HKD","LU1769817096.USD","LU0244354667.USD","LU1066051498.USD","01888","LU0072913022.USD","SGXZ81514606.USD","IE00BQXX3F31.USD","IE0004445239.USD","BK1618","IE00BFMHRM44.USD","LU0868494708.USD","LU2065170008.USD","BK4548","LU2491050071.SGD","LU1868837300.USD","SG9999001424.SGD","IE0034224299.USD","LU0315179316.USD","LU0390134368.USD","LU1861220033.SGD","BK4527","LU2322448957.HKD","BK4605","LU0154236417.USD","LU0516422366.SGD","LU2420271590.USD","BK1589","LU0395794307.EUR","IE0005OL40V9.USD","BK4592","BK1615","LU1105468828.SGD","IE00BZ199S13.USD","01057","IE00BQXX3D17.EUR","LU0820561818.USD","LU0861579265.USD","WISE","LU0228367735.SGD","LU0359201612.USD","LU2237443978.SGD","LU0080751232.USD","LU0345770993.USD","LU0006306889.USD","NVDD","LU0251132253.USD","LU2463028550.USD","LU0708994859.HKD","LU1979441026.SGD","CLIX","LU2242650005.HKD","LU1211504680.USD","LU0143551892.USD","LU0256863811.USD","AGOX","LU2077746001.SGD","SOXQ","LU2125909916.SGD","LU0354030511.USD","LU1035773651.USD","LU1064131342.USD","LU0648948544.HKD","IE00BMPRXQ63.HKD","LU2125154935.USD","LU2347655073.USD","LU2413666699.HKD","LU2294711713.HKD","BK1509","LU2394011477.USD","09995","IE000YTNTUN2.SGD","LU2087621335.USD","ESUM","LU0229945570.USD","01316","LU0787776722.HKD","BK1132","BABW","NVDX","NVDU","LU0823421416.USD","LU0823426308.USD","LU1048588211.SGD","LU1791710582.SGD","LU2083900584.USD","LU1037948541.HKD","BK4524","LU2602419157.SGD","ALBmain","LU0689626769.HKD","LU1794554557.SGD","VT","LU2473716301.USD","NVD3.UK","01797","LU0187121727.USD","LU0061474960.USD","BK4581","LU0109392836.USD","LU2637965513.SGD","LU0106959298.USD","LU2089283258.USD","09888","IE0001KFT4U8.USD","LU0276348264.USD","LU0061475181.USD","LU2357305700.SGD","LU0077335932.USD","IE00BFSS7M15.SGD","LU0942090050.USD","LU2778985437.USD","LU0251143458.SGD","LU1629891620.HKD","LU1548497426.USD","LU0444973449.USD","NVDS","LU0683600562.USD","IE00B775H168.HKD","LU0029864427.USD","LU1699723380.USD","LU0456842615.SGD","LU2552382215.SGD","LU2552382132.HKD","LU1035775433.USD","CLSE","NVDL","LU1769817179.HKD","LU1935042215.USD","LU0158827781.USD","BK4526","LU2750360997.AUD","LU2023250504.SGD","LU0267386448.USD","CHPX","LU1551013342.USD","LU0225283273.USD","BK4535","BK1575","LU1951198990.SGD","LU1688375341.USD","TRFK","NVDQ","LU0174119429.USD","BK1095","LU0287142896.SGD","IE00BN29S564.USD","LU2168563687.JPY","LU0289960550.SGD","LU0347712357.USD","LU2087625088.SGD","LU0494093205.USD","BK4551","IE000KEQY171.SGD","LU0198837287.USD","ANV","BK4588","LU2023251221.USD","LU2065171402.SGD","NVD","LU1242518857.USD","BK1144","LU2250418816.HKD","HK0000304805.HKD","LU2237443622.USD","LU2168564495.EUR","LU2491050154.USD","IE00BQXX3C00.GBP","LU2191332357.HKD","TTXU","SGXZ99366536.SGD","00148","LU0985320562.USD","LU2089985449.USD","LU2746668974.SGD","SG9999015978.USD","DIPS","BK4575","LU1815333072.USD","LU1515016050.SGD","LU0726765562.USD","NVDG","LU2361044949.HKD","LU2360032135.SGD","LU0965509010.AUD","LU2039709279.SGD","LU0672654240.SGD","LU2413666426.HKD","NVYY","IE0009356076.USD","LU1808992512.USD","LU1969619763.USD","LU0203202063.USD","LU0314109678.HKD","LU1732800096.USD","LU2430703178.SGD","LU2237443549.SGD","SNPE","LU3063872942.SGD","ARTY","BK1518","LU2125909759.SGD","SG9999000418.SGD","SG9999014575.USD","LU0096362180.USD","IE00BWXC8680.SGD","LU1935043023.USD","JGRO","BK1506","LU1674673428.USD","SNVDAmain","LU0708995583.HKD","SG9999002463.SGD","09988","LU0965509283.SGD","LU1815336760.USD","LU2931357623.SGD","LU0061474705.USD","ROM","LU2097344357.USD","LU0488056044.USD","BK4502","LU1244550221.USD","LU2168564149.EUR","NVII","LU1880383366.USD","LU0651947912.USD","CMAG","LU2361044865.SGD","FTEC","LU0880133367.SGD","LU1144417596.USD","LU1115378108.SGD","LU1989764664.SGD","LU2746668461.USD","FPA","SOXX","IE00B3M56506.USD","LU0164880469.USD","LU2360106780.USD","IE00BJJMRY28.SGD","LU0797268264.HKD","BABA","BK4554","LU1267930730.SGD","BABU","LU0211328371.USD","LU2125154778.USD","LU1267930490.SGD","LU2322448791.USD","TCHI","LU0353189680.USD","LU1328277881.USD","SG9999004303.SGD","BK4607","LU1951200564.SGD","BK1141","LU1046422090.SGD","LU1496350502.SGD","BK1228","06821","LU2125909593.SGD","LU1400636491.USD","LU0138981039.USD","LU1923623000.USD","LU0823434583.USD","LU1571399168.USD","LU0345768740.USD","IE00B5949003.HKD","LU2097344431.USD","89888","LU1429558221.USD","LU0011850046.USD","SOXY","LU0543330566.HKD","LU0266013472.USD","LU1069344957.HKD","EFIV","LU1633808545.USD","LU0039217434.USD","BK1170","SNVDA2609","LU1821325948.USD","LU1282649141.HKD","LU1481107354.HKD","BK4550","LU0912757837.SGD","SG9999015358.SGD","LU0345768153.USD","LU2237443465.HKD","LU0052750758.USD","LU0210536198.USD","SG9999015945.SGD","IE00BMPRXR70.SGD","LU1934455194.USD","LU0133085943.USD","LU2462591350.SGD","LU0320765059.SGD","LU2756315664.SGD","LU2505996509.AUD","LU0417516738.SGD","LU1232071149.USD","SG9999015986.USD","2NVD.UK","LU2458330243.SGD","LU1670756490.USD","LU0353189763.USD","HK0000914686.HKD","SGXZ23171101.USD","LU0043850808.USD","LU1048596156.SGD","HK0000320223.HKD","LU2249611893.SGD","IE00BFSS8Q28.SGD","LU2108987350.USD","NVDY","BABC","LU2242649171.HKD","LU1084165304.USD","LU0234572021.USD","LU1868836914.USD","SG9999014674.SGD","BABX","002821","LU0965508806.USD","LU1152091168.USD","LU1868837136.USD","VGT","LU1037948897.HKD","LU1992135472.HKD","ESLG","NVC","BK1609","LU2264538146.SGD","LU2543165471.USD","LU0762542818.HKD","02268","IE00BKDWB100.SGD","LU1400636574.HKD","LU2168564065.EUR","LU1880398554.USD","LU2237443382.USD","IE0003U64NQ7.SGD","HK0000819398.USD","LU2247934214.USD","LU2750360641.GBP","SG9999002232.USD","BK4505","LU0079474960.USD","IE00BKVL7J92.USD","LU0320764599.SGD","LU1852331112.SGD","IE00B4YYXB79.USD","NVIW.SI","SG9999015341.SGD","LU0348814723.USD","LU2471134879.HKD","LU0215105999.USD","LU0158827948.USD","BK4122","LU0456846285.SGD","LU0640476718.USD","LU0211327993.USD","LU1496350171.SGD","BIDU","SMH","LU0889565833.HKD","LU0265550359.USD","SNVD.UK","LU0957808578.USD","LU0545039389.USD","LU0096364046.USD","LU0821914370.USD","LU0957791311.USD","SGXZ80539844.SGD","LU0124676726.USD","LU2244417387.USD","LU1316542783.SGD","HK0000306701.USD","LU2237957811.SGD","LU0107464264.USD","LU2290526834.HKD","LU1280957306.USD","07388","SG9999015952.SGD","LU1935042488.USD","LU0918141887.USD","LU1917777945.USD","SG9999018865.SGD","LU2028103732.USD","LU1282649067.USD","BK1161","LU1880398471.USD","LU2462591277.SGD","LU1988902786.USD","LU2133065610.SGD","LU2237443895.HKD","LU2279689827.SGD","LU2047632596.USD","LU1023057109.AUD","LU0823426480.USD","LU0227179875.USD","LU1188198961.HKD","LU1145028129.USD","LU0067412154.USD","IE00BK4W5M84.HKD","LU0979878070.USD","LU1861127337.USD","GAMR","BK4532","BK4549","LU0348735423.USD","LU1778281490.HKD","NVDW","XLK","LU0345769631.USD","FAI","LU0630378429.USD","LU2286300806.USD","IE0034235188.USD","TYLG","LU2491049909.HKD","LU0170899867.USD","LU0384037296.USD","BK4543","BK4141","LU2471134523.USD","IE0004091025.USD","LU2125909247.SGD","BK4531","BK4534","BK4587","LU0516423091.SGD","LU0724617625.USD","688331","LU0057025933.USD","LU2357125470.USD","LU0308772762.SGD","BK4614","LU2272731782.SGD","LU1992135399.USD","LU0949170772.SGD","BK4220","LU1868836591.USD","LU0048584097.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125425592","title":"CSPC Pharma's Recombinant RSV Vaccine Wins US Clinical Trial Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=1125425592","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125425592?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:18","pubTimestamp":1787656739,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that its preventive biologic Class 1 new drug, the recombinant respiratory syncytial virus (RSV) vaccine (SYS6057), has received approval from the US Food and Drug...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","PSYK","LU1152091754.HKD","LU1226287792.SGD","LU1993786604.SGD","LU1226288253.USD","IE00B031HY20.USD","IE0008369823.USD","LU1226287875.USD","BK1521","LU1008478684.HKD","LU1813983027.USD","LU2039709279.SGD","BK1191","BK1515","IBBQ","LU0326950275.SGD","LU1328277881.USD","LU1226287529.USD","LU0314109678.HKD","IE0008368742.USD","IBBJ","BMED","159646","LU1807302812.USD","LU0880133367.SGD","LU0140636845.USD","01093","LU1226288170.HKD","LU1951186391.HKD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0072913022.USD","KURE","LU1960683339.HKD","LU0501845795.SGD","LU0315179316.USD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","SG9999004220.SGD","MDTX","HK0000165453.HKD","LU1152091168.USD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}